Tianjin Medical University Cancer Institute And Hospital

This study tested a combination of two drugs—bevacizumab and a higher dose of icotinib—in 35 people with advanced non-squamous lung cancer that has a specific genetic change (EGFR L858R). The goal was to see if this combo could delay cancer growth better than standard treatment. …

This study tested giving the drugs tislelizumab (alone or with lenvatinib) before surgery for liver cancer that can be removed. The goal was to see if this pre-surgery treatment could shrink tumors and improve outcomes. 36 adults with liver cancer took part. The main measure was …

This study tested whether adding the drug darsilide to standard hormone therapy (exemestane and goserelin) can shrink tumors in premenopausal women with HR-positive, HER2-negative breast cancer. The 119 participants had not responded fully to initial chemotherapy. The main goal w…

This study tested a concentrated plant-based dietary supplement (CPC) in 30 adults with stomach, esophageal, or colorectal cancer who had diarrhea from chemotherapy. The goal was to see if adding CPC to standard diarrhea treatment could help stop the diarrhea faster. Participants…

This study tested a risk scoring model that predicts whether stomach cancer might spread to the liver after surgery. Researchers followed 120 patients who had their stomach cancer removed to see if the model could accurately identify those at higher risk. The goal is to help doct…

This study tested a risk scoring model that predicts whether stomach cancer has spread to lymph nodes before surgery. Researchers collected data from 120 patients who had their stomach cancer removed to see how accurate the model was. The goal is to help doctors plan better treat…

This study tested whether an AI-assisted software (iCurveE) helps doctors outline organs at risk on CT scans for radiation therapy more accurately and quickly. 500 adults with lung, breast, or esophageal cancer participated. Researchers compared manual outlining, AI-only, and AI-…